title: Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009928:Organ Specificity; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D013681:Tegmentum Mesencephali / Q000187:drug effects / Q000378:metabolism*
chemical_list: D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D006220:Haloperidol